ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 581,50
-0,67%
Dow Jones
40 211,72
0,00%
DAX
18 516,19
-0,45%
Brent Oil
82,895
-1,71%
Bitcoin
63 766,39
-1,67%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Constellation Pharmaceuticals Inc (CNST)

  7. Constellation Pharmaceuticals Inc (CNST) Actualités

CNST

Constellation Pharmaceut... (CNST)

Constellation Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CNST
DateHeureSourceTitreSymboleSociété
12/06/201915h00GlobeNewswire Inc.Constellation Pharmaceuticals Presentation Highlights Enhanced EZH2 Target Engagement, Leading to Second-Generation EZH2 Inhi...NASDAQ:CNSTConstellation Pharmaceuticals Inc
10/06/201922h51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNSTConstellation Pharmaceuticals Inc
10/06/201922h35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNSTConstellation Pharmaceuticals Inc
03/06/201915h00GlobeNewswire Inc.Interim Data for CPI-0610 in MANIFEST Clinical Trial Showed Signals of Clinical Activity in Myelofibrosis PatientsNASDAQ:CNSTConstellation Pharmaceuticals Inc
31/05/201917h00GlobeNewswire Inc.Constellation Pharmaceuticals to Present at Jefferies Healthcare ConferenceNASDAQ:CNSTConstellation Pharmaceuticals Inc
23/05/201916h28GlobeNewswire Inc.Constellation Pharmaceuticals to Host Analyst/Investor Meeting at ASCO to Discuss Interim Update of Data of CPI-0610 in MANIF...NASDAQ:CNSTConstellation Pharmaceuticals Inc
20/05/201913h00GlobeNewswire Inc.Constellation Pharmaceuticals Presents Poster on Studies of CPI-0209 in Bladder Cancer at AACR MeetingNASDAQ:CNSTConstellation Pharmaceuticals Inc
16/05/201915h00GlobeNewswire Inc.Constellation Pharmaceuticals Provides Interim Update of Data for CPI-0610 in ASCO and EHA AbstractsNASDAQ:CNSTConstellation Pharmaceuticals Inc
08/05/201922h40Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNSTConstellation Pharmaceuticals Inc
08/05/201922h15GlobeNewswire Inc.Constellation Pharmaceuticals Announces First-Quarter 2019 Financial ResultsNASDAQ:CNSTConstellation Pharmaceuticals Inc
26/04/201913h16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CNSTConstellation Pharmaceuticals Inc
26/04/201913h13Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CNSTConstellation Pharmaceuticals Inc
19/04/201914h00GlobeNewswire Inc.Constellation Pharmaceuticals to Present at the Solebury Trout Class of 2018 Biotech IPOs Investor DayNASDAQ:CNSTConstellation Pharmaceuticals Inc
09/04/201914h55GlobeNewswire Inc.Report: Exploring Fundamental Drivers Behind The Cooper Companies, Encompass Health, SilverCrest Metals, Constellation Pharma...NASDAQ:CNSTConstellation Pharmaceuticals Inc
01/04/201919h00GlobeNewswire Inc.Constellation Pharmaceuticals Presents Results from Phase 1b Portion of ProSTAR Clinical Trial of CPI-1205 at AACR MeetingNASDAQ:CNSTConstellation Pharmaceuticals Inc
15/03/201911h25Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CNSTConstellation Pharmaceuticals Inc
14/03/201922h25Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CNSTConstellation Pharmaceuticals Inc
14/03/201922h24GlobeNewswire Inc.Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2018 Financial ResultsNASDAQ:CNSTConstellation Pharmaceuticals Inc
13/03/201921h20Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CNSTConstellation Pharmaceuticals Inc
06/03/201920h35GlobeNewswire Inc.Constellation Pharmaceuticals to Present at Upcoming Investor ConferenceNASDAQ:CNSTConstellation Pharmaceuticals Inc
04/03/201913h00GlobeNewswire Inc.Constellation Pharmaceuticals Appoints Jessica Christo as Chief Product Development OfficerNASDAQ:CNSTConstellation Pharmaceuticals Inc
22/02/201919h24GlobeNewswire Inc.Constellation Pharmaceuticals to Present at Upcoming Investor ConferencesNASDAQ:CNSTConstellation Pharmaceuticals Inc
21/02/201900h45Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CNSTConstellation Pharmaceuticals Inc
20/02/201913h00GlobeNewswire Inc.Constellation Pharmaceuticals Announces Appointment to Board of DirectorsNASDAQ:CNSTConstellation Pharmaceuticals Inc
14/02/201922h17Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNSTConstellation Pharmaceuticals Inc
13/02/201922h49Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNSTConstellation Pharmaceuticals Inc
03/01/201913h00GlobeNewswire Inc.Constellation Pharmaceuticals Provides Update on MANIFEST Clinical Trial of CPI-0610 in Myelofibrosis, Reviews 2018 Accomplis...NASDAQ:CNSTConstellation Pharmaceuticals Inc
20/12/201819h34GlobeNewswire Inc.Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare ConferenceNASDAQ:CNSTConstellation Pharmaceuticals Inc
10/12/201822h49GlobeNewswire Inc.Constellation Pharmaceuticals Initiates Phase 2 Portion of ProSTAR Clinical Trial in Patients with Metastatic Castration-Resi...NASDAQ:CNSTConstellation Pharmaceuticals Inc
29/11/201820h00GlobeNewswire Inc.Constellation Pharmaceuticals to Present at BMO Healthcare ConferenceNASDAQ:CNSTConstellation Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CNST

Dernières Valeurs Consultées

LSE
HL.
Hargreaves Lansdown
LSE
0MWL
Vaneck Vectors Ucits Etfs
LSE
0GHF
Cimco Marine Ab
LSE
UC14
Ubsetf Ccusas
LSE
IEBC
Ishrc Euro
FX
USDRUB
US Dollar vs RUB
NASDAQ
ERES
East Resources Acquisition
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés